Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Regenerative Medical Technology Group 3-Year ROIIC %?
Regenerative Medical Technology GroupRMTG +26.42% 3-Year ROIIC % is 3.28 as of Dec. 2025, which is 277% above its 10-year median of 0.87. The stock has 6 warning signs investors should review. Among 1,323 Biotechnology companies, Regenerative Medical Technology Group ranks better than 55.93% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Regenerative Medical Technology Group's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 3.28%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
RMTG's 3-Year ROIIC % is ranked better than 55.93% of 1323
companies
in the Biotechnology industry
Industry Median: -4.85
vs RMTG: 3.28
Regenerative Medical Technology Group (OTCPK:RMTG) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Regenerative Medical Technology Group 3-Year ROIIC % Related Terms
Regenerative Medical Technology Group 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regenerative Medical Technology Group 3-Year ROIIC % Chart
RMTG vs PTIX, CERO, EMMA: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Regenerative Medical Technology Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regenerative Medical Technology Group 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Regenerative Medical Technology Group's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.867 (Dec. 2025) - -1.185 (Dec. 2022) )
/
( 23.183 (Dec. 2025) - 13.482 (Dec. 2022) )
=
0.318
/
9.701
=
3.28%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Regenerative Medical Technology Group (RMTG) has a 3-Year ROIIC % of 3.28 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Regenerative Medical Technology Group and its competitors. This is 277% above median its historical median of 0.87. According to the industry distribution chart, Regenerative Medical Technology Group ranks #583 out of 1323 companies in the Biotechnology industry, placing it in the top 44.1%.
Is Regenerative Medical Technology Group's 3-Year ROIIC % too high?
Regenerative Medical Technology Group's current 3-Year ROIIC % of 3.28 is 277% above median its 10-year median of 0.87. Based on the distribution chart, Regenerative Medical Technology Group ranks #583 out of 1323 companies in the Biotechnology industry, which is above the industry midpoint.
How does Regenerative Medical Technology Group's 3-Year ROIIC % compare to PTIX and CERO?
According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #583 out of 1323 companies for 3-Year ROIIC %. This puts Regenerative Medical Technology Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Regenerative Medical Technology Group and its competitors. Regenerative Medical Technology Group's current 3-Year ROIIC % is 3.28, which is 277% above median its own 10-year median of 0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.06, compared to a current price of $0.09 — trading 48.3% above its estimated fair value. The current 3-Year ROIIC % is 3.28, which is 277% above median its 10-year median of 0.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current 3-Year ROIIC % is 3.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Regenerative Medical Technology Group Business Description
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RMTG has been successfully added to your 
